Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 24:13:1118028.
doi: 10.3389/fonc.2023.1118028. eCollection 2023.

Application and evaluation of transitory protective stoma in ovarian cancer surgery

Jiaqi He  1 , Jinke Li  1 , Bao Fan  1 , Liya Yan  1 , Ling Ouyang  1
Affiliations
Review

Application and evaluation of transitory protective stoma in ovarian cancer surgery

Jiaqi He et al. Front Oncol. .

Abstract

Ovarian cancer is the most fatal of all female reproductive cancers. The fatality rate of OC is the highest among gynecological malignant tumors, and cytoreductive surgery is a common surgical procedure for patients with advanced ovarian cancer. To achieve satisfactory tumor reduction, intraoperative bowel surgery is often involved. Intestinal anastomosis is the traditional way to restore intestinal continuity, but the higher rate of postoperative complications still cannot be ignored. Transitory protective stoma can reduce the severity of postoperative complications and traumatic stress reaction and provide the opportunity for conservative treatment. But there are also many problems, such as stoma-related complications and the impact on social psychology. Therefore, it is essential to select appropriate patients according to the indications for the transitory protective stoma, and a customized postoperative care plan is needed specifically for the stoma population.

Keywords: colorectal resection; cytoreductive surgery; gynecological oncology surgery; ovarian cancer; transitory protective stoma.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin (2020) 70(1):7–30. doi: 10.3322/caac.21590 - DOI - PubMed
    1. Thigpen T, duBois A, McAlpine J, DiSaia P, Fujiwara K, Hoskins W, et al. . First-line therapy in ovarian cancer trials. Int J Gynecol Cancer (2011) 21(4):756–62. doi: 10.1097/IGC.0b013e31821ce75d - DOI - PubMed
    1. Patankar S, Burke WM, Hou JY, Tergas AI, Huang Y, Ananth CV, et al. . Risk stratification and outcomes of women undergoing surgery for ovarian cancer. Gynecol Oncol (2015) 138(1):62–9. doi: 10.1016/j.ygyno.2015.04.037 - DOI - PMC - PubMed
    1. Aletti GD, Dowdy SC, Gostout BS, Jones MB, Stanhope CR, Wilson TO, et al. . Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet Gynecol (2006) 107(1):77–85. doi: 10.1097/01.AOG.0000192407.04428.bb - DOI - PubMed
    1. Son JH, Kong TW, Paek J, Chang SJ, Ryu HS. Perioperative outcomes of extensive bowel resection during cytoreductive surgery in patients with advanced ovarian cancer. J Surg Oncol (2019) 119(7):1011–5. doi: 10.1002/jso.25403 - DOI - PubMed

LinkOut - more resources